药物使用与减少伤害政策：关于加利福尼亚提案的不同观点
Drug use and harm reduction policy: alternative perspectives on the California proposal.
作者信息
Stauffer Laura
机构信息
Department of Social Welfare, University of California, Berkeley, CA 94720-7400, USA.
出版信息
J Health Soc Policy. 2004;19(3):19-36. doi: 10.1300/j045v19n03_02.
On October, 12, 2003, then California Governor Gray Davis vetoed legislation which would have created a trial period for evaluating nonprescription pharmacy access to needles and syringes for adults in California. An analysis of California Senate Bill 774 provides a case study to examine the struggle for clean syringe and needle access as a component of disease prevention along with the community fear of tacit approval for illicit drug use. Reflecting upon the empirically-supported research and community concerns for this specific type of harm reduction policy is an important step towards forming common political ground. This article underscores the relevance of syringe deregulation and its relevance as an ethical and political issue for social workers.
2003年10月12日，时任加利福尼亚州州长的格雷·戴维斯否决了一项立法，该立法本可为评估加利福尼亚州成年人通过非处方药房获取针头和注射器设立一个试验期。对加利福尼亚州参议院第774号法案的分析提供了一个案例研究，以审视获取清洁注射器和针头作为疾病预防组成部分的斗争，以及社区对非法药物使用默认许可的担忧。反思针对这种特定类型减少伤害政策的实证研究和社区关切，是形成共同政治基础的重要一步。本文强调了注射器管制放松的相关性及其作为社会工作者面临的伦理和政治问题的相关性。
Zotero 插件